Kamaitachi Yamauchi also tried it and lost 8 kg in 3 months.
The risk of “pancreatitis,” which could kill you, is 9 times higher.
If I die from this, I won’t be able to face my family…Mr. A, a resident of Kanagawa Prefecture, was scared when he was about to be injected with a slimming drug. This was the case last winter during a trial program at a clinic where the GLP-1 diet is available. The program is free of charge and not covered by health insurance.
I went there after seeing an ad on a social networking service. Counseling, one trial of the high-frequency slimming machine in one spot, one injection of the smallest dose of GLP-1. ＋Plus a program where I get a 3-day supply of SGLT2 inhibitors.”
The subcutaneous injection of the GLP-1 receptor agonist is as simple as a prick in the stomach, but I suddenly felt scared. Because Ms. A is healthy but chubby, and although she has had a desire to lose just three more kilograms for the past 20 years, she has never followed a diet or exercise program. That is why she decided to try this trial program.
The “GLP-1 diet” that Ms. A experienced is also called a “medical diet,” and in recent years, an increasing number of medical institutions have been prescribing the drug through free medical treatment and online medical services, with the selling point that weight loss can be achieved easily and without strain simply by taking the drug.
In April of this year, Kenji Yamauchi (42) of the comedy duo “Kamaitachi” reported in a YouTube video that he had successfully lost 8 kg through the “diet of injections in the stomach.
He said, “It suppresses my appetite first.”
About half of the sugar and other substances you consume are eliminated with urine.
The duo also revealed that they had received treatment at a hair loss clinic where they appeared in a commercial and were prescribed the injections. The video included the warning, “This video is based on Yamauchi’s personal experience and opinion.” However, the video was closed to the public after only two days due to various opinions, such as “a drug with life-threatening side effects” and “dangerous if not managed properly.
The GLP-1 receptor agonists and SGLT2 inhibitors used in the GLP-1 diet are not drugs for weight loss. The main function of GLP-1 receptor agonists is to stimulate the secretion of insulin from the pancreas, and the secreted insulin lowers blood glucose levels. SGLT2 inhibitors lower blood glucose levels by inhibiting glucose reabsorption in the kidneys. They are not indicated for use in slimming and dieting.
These two drugs have become popular because, in addition to their blood glucose-lowering effects, they are the first drugs that can prevent serious complications of diabetes, such as heart and kidney failure. The fact that they also have the ability to reduce weight has attracted a great deal of attention, and demand for off-label use for slimming and dieting has increased, making GLP-1 receptor agonists difficult to obtain around the world today.
